Sandip Kapadia Biography and Net Worth

Chief Financial Officer and Chief Administrative Officer of Harmony Biosciences

Mr. Kapadia is Chief Financial Officer and Chief Administrative Officer. He has over 25 years of life sciences industry experience across multiple therapeutic areas and has provided strategic financial oversight and guidance to companies both in the United States and Europe. Most recently, Mr. Kapadia served as Chief Financial Officer at Intercept Pharmaceuticals, Inc., a biopharmaceutical company, from July 2016 to March 2021 where he built upon the company’s key functional capabilities, developed, and executed financial and capital strategies to prepare for commercial launch. Prior to joining Intercept, Mr. Kapadia served in various financial leadership capacities over 19 years at Novartis International AG and Novartis affiliates in the United States, Switzerland, the Netherlands, and the United Kingdom. He also serves as a director of Molecular Partners AG, Passage Bio, and Alentis Therapeutics. Mr. Kapadia received a Master of Business Administration (MBA) from Rutgers Graduate School of Management and a bachelor’s degree from Montclair State University and is also a US Certified Public Accountant.

What is Sandip Kapadia's net worth?: The estimated net worth of Sandip Kapadia is at least $793,312.34 as of December 15th, 2020. Mr. Kapadia owns 27,158 shares of Harmony Biosciences stock worth more than $793,312 as of April 11th. This net worth approximation does not reflect any other investments that Mr. Kapadia may own. Additionally, Mr. Kapadia receives an annual salary of $813,520.00 as Chief Financial Officer and Chief Administrative Officer at Harmony Biosciences. Learn More about Sandip Kapadia's net worth.
How old is Sandip Kapadia?: Mr. Kapadia is currently 54 years old. There are 2 older executives and no younger executives at Harmony Biosciences. The oldest executive at Harmony Biosciences is Dr. Jeffrey M. Dayno M.D., President, CEO & Director, who is 67 years old. Learn More on Sandip Kapadia's age.
What is Sandip Kapadia's salary?: As the Chief Financial Officer and Chief Administrative Officer of Harmony Biosciences Holdings, Inc., Mr. Kapadia earns $813,520.00 per year. The highest earning executive at Harmony Biosciences is Dr. Jeffrey M. Dayno M.D., President, CEO & Director, who commands a salary of $1,260,000.00 per year. Learn More on Sandip Kapadia's salary.
How do I contact Sandip Kapadia?: The corporate mailing address for Mr. Kapadia and other Harmony Biosciences executives is 630 W GERMANTOWN PIKE SUITE 215, PLYMOUTH MEETING PA, 19462. Harmony Biosciences can also be reached via phone at 484-539-9800 and via email at lcaperelli@harmonybiosciences.com. Learn More on Sandip Kapadia's contact information.
Has Sandip Kapadia been buying or selling shares of Harmony Biosciences?: Sandip Kapadia has not been actively trading shares of Harmony Biosciences over the course of the past ninety days. Most recently, Sandip Kapadia sold 1,775 shares of the business's stock in a transaction on Monday, January 27th. The shares were sold at an average price of $38.05, for a transaction totalling $67,538.75. Learn More on Sandip Kapadia's trading history.
Who are Harmony Biosciences' active insiders?: Harmony Biosciences' insider roster includes Jeffrey Dayno (Insider), Jeffrey Dierks (Insider), John Jacobs (CEO), Sandip Kapadia (Chief Financial Officer and Chief Administrative Officer), and Andreas Wicki (Director). Learn More on Harmony Biosciences' active insiders.
Are insiders buying or selling shares of Harmony Biosciences?: In the last year, insiders at the sold shares 9 times. They sold a total of 94,148 shares worth more than $3,709,632.36. The most recent insider tranaction occured on January, 27th when insider Jeffrey Dierks sold 1,629 shares worth more than $61,934.58. Insiders at Harmony Biosciences own 30.8% of the company. Learn More about insider trades at Harmony Biosciences.
Information on this page was last updated on 1/27/2025.

Sandip Kapadia Insider Trading History at Harmony Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
1/27/2025	Sell	1,775	$38.05	$67,538.75
1/21/2025	Sell	25,000	$40.18	$1,004,500.00

Sandip Kapadia Buying and Selling Activity at Harmony Biosciences

Harmony Biosciences Company Overview

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.

Today's Range

Now: $29.17

$27.63

$29.38

50 Day Range

MA: $34.08

$28.13

$39.36

2 Week Range

Now: $29.17

$26.47

$41.61

Volume

827,269 shs

Average Volume

567,833 shs

Market Capitalization

$1.67 billion

P/E Ratio

13.82

Dividend Yield

N/A

Beta

0.8

Sandip Kapadia Biography and Net Worth

What is Sandip Kapadia's net worth?

How old is Sandip Kapadia?

What is Sandip Kapadia's salary?

How do I contact Sandip Kapadia?

Has Sandip Kapadia been buying or selling shares of Harmony Biosciences?

Who are Harmony Biosciences' active insiders?

Are insiders buying or selling shares of Harmony Biosciences?